Advertisement
News
Advertisement

Alkermes advances another addiction drug

Mon, 10/25/2010 - 11:37am
Mass High Tech: The Journal of New England Technology

Alkermes Inc. has announced positive results from an early stage clinical trial testing the efficacy of its drug candidate ALKS 33 in treating cocaine addiction.

The company also said it has been awarded a grant of up to $2.4 million from the National Institute on Drug Abuse Grants to speed up development of the potential therapy.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading